Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 13, 2018

SELL
$16.16 - $31.31 $717,293 - $1.39 Million
-44,387 Closed
0 $0
Q4 2017

Jan 29, 2018

BUY
$12.26 - $25.88 $544,184 - $1.15 Million
44,387
44,387 $736,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $257M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Verde Servicos Internacionais S.A. Portfolio

Follow Verde Servicos Internacionais S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verde Servicos Internacionais S.A., based on Form 13F filings with the SEC.

News

Stay updated on Verde Servicos Internacionais S.A. with notifications on news.